Long-Term Stability of the Glide Control Strategy

November 3, 2025 updated by: Infinite Biomedical Technologies

Determining the Long-Term Stability of the Glide Control Strategy for Upper Limb Prostheses

This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern Recognition-based advanced myoelectric control. The goal of the study is to fill the gaps in clinically relevant knowledge to inform the prescription of prosthesis components and the rehabilitation process.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Maryland
      • Annapolis, Maryland, United States, 21401
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Annapolis
        • Contact:
      • Baltimore, Maryland, United States, 21227
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Baltimore
        • Contact:
      • Silver Spring, Maryland, United States, 20910
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Silver Spring
        • Contact:
    • Massachusetts
      • Allston, Massachusetts, United States, 02134
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Allston
        • Contact:
      • Milton, Massachusetts, United States, 02186
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Milton
        • Contact:
    • North Carolina
      • Charlotte, North Carolina, United States, 28210
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Charlotte
        • Contact:
    • South Carolina
      • Anderson, South Carolina, United States, 29621
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Anderson
        • Contact:
      • Greenville, South Carolina, United States, 29615
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Greenville
        • Contact:
    • Virginia
      • Fairfax, Virginia, United States, 22031
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Fairfax
        • Contact:
      • Leesburg, Virginia, United States, 20176
        • Recruiting
        • Medical Center Orthotics and Prosthetics - Leesburg
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Unilateral trans-radial or trans-humeral limb loss with a healed residual limb
  • Candidate for 2+ degree-of-freedom (DOF) myoelectric prosthesis as determined by the study prosthetist
  • Age of 18 years or greater

Exclusion Criteria:

  • Prior experience with Pattern Recognition or Glide control
  • Individuals with a residual limb that is unhealed from the amputation surgery
  • Individuals with easily damaged or sensitive skin who would not tolerate EMG electrodes
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Glide then Pattern Recognition
Participants use a Glide-controlled upper limb prosthesis first, followed by a Pattern Recognition-based upper limb prosthesis.
Device: Glide Control System
Glide is a commercially developed directional myoelectric control strategy from Infinite Biomedical Technologies (IBT) that sits between classic Direct Control (DC) and modern Pattern Recognition (PR). Instead of requiring an isolated on/off muscle signal for each function (e.g., DC) or training a complex classifier on many gestures (e.g., PR), Glide uses the relative activity across 2-8 EMG electrodes to move a virtual cursor on a 2-D "Glide map." The map is divided into adjustable sectors ("slices"), and each slice is assigned a prosthetic movement (e.g., hand open/close, wrist rotation, elbow flexion). Moving the cursor into a slice actuates that movement.
Device: Pattern Recognition System
Pattern recognition (PR)-based myoelectric control is a data-driven approach that allows a user to control multiple prosthetic functions using natural muscle activation patterns rather than discrete, isolated signals. Instead of mapping one muscle to one motion (as in conventional Direct Control), PR systems record the spatial and temporal pattern of EMG activity from multiple sites on the residual limb and use machine learning algorithms to classify which intended movement the user is trying to make.
Experimental: Pattern Recognition then Glide
Participants use a Pattern Recognition-based upper limb prosthesis first, followed by a Glide-controlled upper limb prosthesis.
Device: Glide Control System
Glide is a commercially developed directional myoelectric control strategy from Infinite Biomedical Technologies (IBT) that sits between classic Direct Control (DC) and modern Pattern Recognition (PR). Instead of requiring an isolated on/off muscle signal for each function (e.g., DC) or training a complex classifier on many gestures (e.g., PR), Glide uses the relative activity across 2-8 EMG electrodes to move a virtual cursor on a 2-D "Glide map." The map is divided into adjustable sectors ("slices"), and each slice is assigned a prosthetic movement (e.g., hand open/close, wrist rotation, elbow flexion). Moving the cursor into a slice actuates that movement.
Device: Pattern Recognition System
Pattern recognition (PR)-based myoelectric control is a data-driven approach that allows a user to control multiple prosthetic functions using natural muscle activation patterns rather than discrete, isolated signals. Instead of mapping one muscle to one motion (as in conventional Direct Control), PR systems record the spatial and temporal pattern of EMG activity from multiple sites on the residual limb and use machine learning algorithms to classify which intended movement the user is trying to make.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily Mean Number of Control Adjustment Sessions (DMNCAS)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to the End of Treatment (Day 168)
DMNCAS quantifies the number of times a prosthesis user needs to adjust their control strategy to maintain performance. For a PR system, a control adjustment refers to a calibration (or recalibration) of one or more prosthesis movements, while for the Glide control strategy, a control adjustment refers to a change in the Glide map configuration (e.g., electrode gains, slice geometries, assigned movements, etc.). A control adjustment session is then a period of time devoted to performing one or more control adjustments. The number and duration of control adjustment sessions will be recorded in a study diary.
Weekly, From Prosthesis Delivery (Day 0) to the End of Treatment (Day 168)
Number of Follow-Up Clinical Interventions (NFCI)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
NFCI reports the number of times the prosthesis user requests the aid of a clinician to resolve an issue with their prescribed control strategy. NFCI refers to clinical interventions (both remote and in-person) that occur post-prosthesis delivery, the number and duration of which will be recorded in a study diary. Diary entries will be verified through a retrospective chart review in collaboration with Medical Center Orthotics & Prosthetics.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socket Comfort Score (SCS)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
SCS is a validated, 11-point numerical rating scale that quantifies a respondent's subjective experience of comfort while wearing a prosthesis. The score ranges from 0 (or "the least comfortable socket fit you can imagine") to 10 (or "the most comfortable socket you can imagine"). A higher score indicates a more comfortable socket fit. Full administration of the SCS is estimated to take about 5 minutes.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
Numerical Pain Rating Scale (NPRS)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
NPRS is a pain screening tool that uses two 0 to 10 scales to measure pain intensity over the last seven days. The two scales interrogate different dimensions of pain: 1) residual limb pain; and 2) phantom limb pain. Both scales include descriptive anchors at the extremes (i.e., "no pain" is 0 and "the highest pain you can imagine" is 10). A higher score indicates a more intense pain experience. Full administration of the NPRS is estimated to take about 5 minutes.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
PROMIS Pain Interference - Short Form 4a
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
PROMIS Pain Interference short form 4a is a validated, self-report questionnaire that assesses consequences of pain on relevant aspects of one's life, including the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. The assessment comprises of four, 5-point Likert-type questions, each querying the respondent on their experience of pain in the previous seven days. PROMIS instruments are scored on a T-score metric (0 - 100) in which 50 is the mean of the reference population and 10 is the standard deviation. In general, a higher score equals more of the concept being measured. For the PROMIS Pain Interference questionnaire, a higher score then indicates a greater degree to which individuals believe pain interferes with their daily lives. Full administration of the PROMIS Pain Interference short form 4a is estimated to take about 5 minutes.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
PROMIS Satisfaction - Short Form 8a
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
PROMIS Satisfaction short form 8a is a validated, self-report questionnaire designed to query individuals on their satisfaction with their ability to participate in social roles and activities. The survey consists of eight, 5-point Likert-type questions covering several aspects of social engagement, including work, recreation, and maintaining interpersonal relationships. A higher score indicates a higher satisfaction with the respondent's ability to participate in work and home life. Full administration of the PROMIS Satisfaction short form 8a is estimated to take about 10 minutes.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
OPUS Upper Extremity Functional Scale (UEFS)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
OPUS UEFS is a validated, self-report questionnaire that asks respondents to score how easily they can complete several activities of daily living (e.g., drink from a paper cup, brush hair, etc.). It is a low burden measure that provides a subjective view of a participant's functionality with a prosthesis. OPUS UEFS includes a total of 28 questions, each regarding an activity of daily living. Responses are divided into two parts: 1) a 5-point, Likert-type scale with descriptive anchors for each Level of Ease (e.g., "Cannot perform activity" is 0, "Very easy" is 4); and 2) an indication on if the activity is usually performed with or without a prosthesis. Participants may also provide a null response (i.e., "Not applicable") if they believe that the activity does not apply to them. The total score of the OPUS UEFS is the sum of the 28 responses converted to a Rasch measure (0 - 100). Higher scores therefore indicate greater functionality. Full administration takes about 25 minutes.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
Mean Daily Prosthesis Wear Duration (MDPWD)
Time Frame: Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)
MDPWD acts as a proxy for improved prosthesis acceptance. Prosthesis wear time is defined as the time from when participants don their prostheses to the time they doff their prostheses. Prosthesis wear duration is self-reported (in hours) by participants via a study diary.
Weekly, From Prosthesis Delivery (Day 0) to End of Treatment (Day 168)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Infinite Biomedical Technologies

Collaborators

Medical Center Orthotics and Prosthetics

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2025

Primary Completion (Estimated)

November 1, 2028

Study Completion (Estimated)

April 1, 2029

Study Registration Dates

First Submitted

October 27, 2025

First Submitted That Met QC Criteria

October 27, 2025

First Posted (Estimated)

October 29, 2025

Study Record Updates

Last Update Posted (Estimated)

November 5, 2025

Last Update Submitted That Met QC Criteria

November 3, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • OR240247

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Limb Amputation Below Elbow

Clinical Trials on Glide Control System

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe